| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Advancing academia-driven treatment optimisation in oncology: Launch of the EMA Cancer Medicines Forum
|
Saesen, Robbe
|
|
|
168 |
C |
p. 77-79
|
artikel
|
| 2 |
An elevated FIB-4 score is associated with an increased incidence of liver cancer: A longitudinal analysis among 248,224 outpatients in Germany
|
Loosen, Sven H.
|
|
|
168 |
C |
p. 41-50
|
artikel
|
| 3 |
Congenital spindle cell rhabdomyosarcoma: An international cooperative analysis
|
Whittle, Sarah
|
|
|
168 |
C |
p. 56-64
|
artikel
|
| 4 |
Early discontinuation and failure to publish clinical trials of haematologic cancer interventions: A retrospective observational study
|
Wayant, Cole
|
|
|
168 |
C |
p. 65-67
|
artikel
|
| 5 |
Encorafenib plus cetuximab treatment in BRAF V600E-mutated metastatic colorectal cancer patients pre-treated with an anti-EGFR: An AGEO-GONO case series
|
Hafliger, Emilie
|
|
|
168 |
C |
p. 34-40
|
artikel
|
| 6 |
Impact of trough concentrations of regorafenib and its major metabolites M-2 and M-5 on overall survival of chemorefractory metastatic colorectal cancer patients: Results from a multicentre GERCOR TEXCAN phase II study
|
Rousseau, Benoit
|
|
|
168 |
C |
p. 99-107
|
artikel
|
| 7 |
Letter comments on: D2 dissection improves disease-specific survival in advanced gastric cancer patients: 15-year follow-up results of the Italian gastric cancer study group D1 versus D2 randomised controlled trial
|
Zhou, Yong
|
|
|
168 |
C |
p. 141-142
|
artikel
|
| 8 |
Osteosarcoma: Novel prognostic biomarkers using circulating and cell-free tumour DNA
|
Lyskjær, Iben
|
|
|
168 |
C |
p. 1-11
|
artikel
|
| 9 |
Overall survival is the lowest among young women with postpartum breast cancer
|
Shagisultanova, Elena
|
|
|
168 |
C |
p. 119-127
|
artikel
|
| 10 |
Overall survival with palbociclib plus endocrine therapy versus capecitabine in postmenopausal patients with hormone receptor-positive, HER2-negative metastatic breast cancer in the PEARL study
|
Martín, Miguel
|
|
|
168 |
C |
p. 12-24
|
artikel
|
| 11 |
Pathological and genetic markers improve recurrence prognostication with the University of California Los Angeles Integrated Staging System for patients with clear cell renal cell carcinoma
|
Kroeger, Nils
|
|
|
168 |
C |
p. 68-76
|
artikel
|
| 12 |
Phase 1 study of the liposomal formulation of eribulin (E7389-LF): Results from the breast cancer expansion cohort
|
Masuda, Norikazu
|
|
|
168 |
C |
p. 108-118
|
artikel
|
| 13 |
Predicting 10-year survival after resection of colorectal liver metastases; an international study including biomarkers and perioperative treatment
|
Buisman, Florian E.
|
|
|
168 |
C |
p. 25-33
|
artikel
|
| 14 |
Quality of life assessment of cabozantinib in patients with advanced hepatocellular carcinoma in the CELESTIAL trial
|
Freemantle, Nick
|
|
|
168 |
C |
p. 91-98
|
artikel
|
| 15 |
Seropositivity and neutralising antibodies at six months after BNT162b2 vaccination in patients with solid tumours
|
Margalit, Ofer
|
|
|
168 |
C |
p. 51-55
|
artikel
|
| 16 |
The European Neuroendocrine Tumour Society registry, a tool to assess the prognosis of neuroendocrine neoplasms
|
Borbath, Ivan
|
|
|
168 |
C |
p. 80-90
|
artikel
|
| 17 |
Tumour-infiltrating lymphocytes add prognostic information for patients with low-risk DCIS: findings from the SweDCIS randomised radiotherapy trial
|
Schiza, Aglaia
|
|
|
168 |
C |
p. 128-137
|
artikel
|
| 18 |
Tumour infiltrating lymphocytes and ductal carcinoma in situ: The art of thinking counterintuitively
|
Salgado, Roberto
|
|
|
168 |
C |
p. 138-140
|
artikel
|
Tijdschrift beschrijving